Purpose: The FAT1 gene encodes FAT atypical cadherin 1, which is essential for foetal development, including brain development. This study aimed to investigate the relationship between FAT1 variants and epilepsy.
Methods: Trio-based whole-exome sequencing was performed on a cohort of 313 patients with epilepsy. Additional cases with FAT1 variants were collected from the China Epilepsy Gene V.1.0 Matching Platform.
Results: Four pairs of compound heterozygous missense FAT1 variants were identified in four unrelated patients with partial (focal) epilepsy and/or febrile seizures, but without intellectual disability/developmental abnormalities. These variants presented no/very low frequencies in the gnomAD database, and the aggregate frequencies in this cohort were significantly higher than those in controls. Two additional compound heterozygous missense variants were identified in two unrelated cases using the gene-matching platform. All patients experienced infrequent (yearly/monthly) complex partial seizures or secondary generalised tonic-clonic seizures. They responded well toantiseizure medication, but seizures relapsed in three cases when antiseizure medication were decreased or withdrawn after being seizure-free for three to six years, which correlated with the expression stage of FAT1. Genotype-phenotype analysis showed that epilepsy-associated FAT1 variants were missense, whereas non-epilepsy-associated variants were mainly truncated. The relationship between FAT1 and epilepsy was evaluated to be "Strong" by the Clinical Validity Framework of ClinGen.
Conclusions: FAT1 is a potential causative gene of partial epilepsy and febrile seizures. Gene expression stage was suggested to be one of the considerations in determining the duration ofantiseizure medication. Genotype-phenotype correlation helps to explain the mechanisms underlying phenotypic variation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.seizure.2023.03.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Discover Mutational Differences Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma and Search for More Effective Biomarkers for Immunotherapy.
Cancer Manag Res
December 2024
Department of Pulmonary Medicine, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830001, People's Republic of China.
Purpose: Lung cancer is a severe malignant tumor. This study aims to more comprehensively characterize lung cancer patients and identify combination markers for immunotherapy.
Patients And Methods: We gathered data from 166 lung cancer patients at the Cancer Hospital Affiliated with Xinjiang Medical University.
Genetic heterogeneity in familial forms of genetic generalized epilepsy: from mono- to oligogenism.
Hum Genomics
November 2024
Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS - Hôpital La Pitié-Salpêtrière, Paris, France.
Article Synopsis
- - Genetic generalized epilepsy (GGE) includes types like childhood absence epilepsy and juvenile myoclonic epilepsy, showing a higher risk of occurrence in first-degree relatives of affected individuals, suggesting a strong genetic component.
- - Research, including whole exome sequencing from families in Sudan, has identified specific genetic variants linked to GGE, indicating it is genetically diverse and likely influenced by multiple genes rather than a single cause.
- - The study emphasizes the importance of examining familial cases, as well as using populations with unique genetic backgrounds, to better understand the complex genetics of GGE, reinforcing the idea that it may have oligogenic inheritance patterns.
Mutations of ARID1B, PIK3C2B, KMT2B, and FAT1 genes influence clinical outcome in newly diagnosed myeloma.
Cancer Genet
November 2024
Department of Experimental Haematooncology, Medical University of Lublin, Lublin, Poland.
The study aimed to elucidate the mutational profile of patients with newly diagnosed multiple myeloma to understand correlations of alterations with clinical outcomes. A cohort of 20 patients was enrolled, and mutational analysis was conducted using the TruSight Oncology 500 DNA Kit. Identified genetic alterations were related to clinicopathologic features and treatment outcomes.
View Article and Find Full Text PDFWhole‑exome sequencing insights into synchronous bilateral breast cancer with discordant molecular subtypes.
Oncol Lett
December 2024
Department of Pathology, The First Affiliated Hospital of Dali University, Dali, Yunnan 671000, P.R. China.
The incidence of synchronous bilateral breast cancer (SBBC) is very low, and SBBC with discordant molecular subtypes is even more uncommon. As such, little is known about the pathogenesis of SBBC with discordant molecular subtypes, and reports about this entity are scarce. In the present study, the case of a 72-year-old female patient who presented with SBBC with discordant molecular subtypes is reported, with a stage IA hormone receptor negative {human epidermal growth factor receptor-2 [HER2(+)]} tumor in the left breast and a stage IIIA hormone sensitive tumor [HER2(-)] in the right breast.
View Article and Find Full Text PDFPediatric Angiosarcoma with Novel Phenotypic and Genotypic Profile in Chinese Children.
Fetal Pediatr Pathol
November 2024
Department of Pathology, Children's Hospital of Fudan University, Shanghai, China.
Angiosarcoma is an exceedingly rare entity in pediatric population. Herein, we report two pediatric angiosarcoma with novel phenotypic and genotypic profile. The two patients' information was summarized by clinical data, histopathology, immunohistochemistry, genetic, treatment, and prognosis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!